Defective dynamic properties of human cardiac troponin mutations

Michael W Lassalle1

  • 1Senior Research Fellow Center, Ehime University, Japan. jpwml@ccr.ehime-u.ac.jp

Insights

Mutations in cardiac troponin I (TnI) and troponin T (TnT) cause hypertrophic cardiomyopathy (HCM). This study reveals how these mutations alter protein dynamics, impacting cardiac function and providing insights into HCM mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Mutations in cardiac troponin I (TnI) and troponin T (TnT) are linked to familial hypertrophic cardiomyopathy (FHC) and hypertrophic cardiomyopathy (HCM).
  • The precise molecular mechanisms underlying these cardiac conditions, particularly concerning protein dynamics, remain incompletely understood.
  • Altered dynamic properties of human cardiac troponin (hcTn) may explain functional aberrations.

Purpose of the Study:

  • To investigate the hypothesis that defective dynamic properties of hcTroponin contribute to FHC and HCM.
  • To elucidate the molecular basis of functional changes caused by specific TnI and TnT mutations.

Main Methods:

  • Utilized detailed Nuclear Magnetic Resonance (NMR) relaxation measurements on isotopically labeled proteins ([(2)H, (13)C, (15)N]).
  • Reconstituted wild-type and mutant troponin complexes (TnI, TnT) into hcTroponin.
  • Performed measurements in both calcium- (Ca2+) and magnesium- (Mg2+) loaded states.

Main Results:

  • Significant dynamic changes were observed in the regions responsible for Troponin C (TnC) binding and actin-tropomyosin (Tm) interaction for all investigated mutations (TnI(G203S), TnI(DeltaK183), TnT(R278P)).
  • These findings indicate that mutations in both TnI and TnT affect the overall dynamics of the troponin complex.
  • The study identified specific areas of dynamic alteration relevant to FHC and HCM pathogenesis.

Conclusions:

  • The study provides crucial insights into the functional consequences of FHC and HCM-associated mutations in human cardiac troponin.
  • Altered protein dynamics in key interaction sites are demonstrated to be a significant factor in the pathophysiology of HCM.
  • These findings advance our understanding of the molecular mechanisms driving inherited cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...